Maintenance fees coming due
Hadasit Medical Research Services and Development Ltd.
23 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Dec 4, 2026. Unpaid by Jun 4, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,307,462 | Compositions and Methods for Inducing Thrombopoiesis In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | Hadasit Medical Research Services and Development Ltd. | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 10,314,873 | Method of Treatment of Diseases Using Hoodia Extracts Hadasit Medical Research Services & Development Ltd. and Desert Labs Agriculture Cooperative Association Ltd. In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Hadasit Medical Research Services & Development Ltd. and Desert Labs Agriculture Cooperative Association Ltd. | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 10,336,985 | Method of Obtaining Terminally Differentiated Neuronal Lineages and Uses Thereof In force Fee due Jan 2, 2027 Lapses if unpaid Jul 2, 2027 · High confidence | Hadasit Medical Research Services & Development Limited | In force | Jan 2, 2027 | Jul 2, 2027 | High confidence | |
| US 9,072,737 | tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS In force Fee due Jan 7, 2027 Lapses if unpaid Jul 7, 2027 · High confidence | Hadasit Medical Research Services & Development Ltd. | In force | Jan 7, 2027 | Jul 7, 2027 | High confidence | |
| US 10,344,073 | Improved Cell Compositions and Methods for Cancer Therapy In force Fee due Jan 9, 2027 Lapses if unpaid Jul 9, 2027 · High confidence | Hadasit Medical Research Services and Development Ltd. | In force | Jan 9, 2027 | Jul 9, 2027 | High confidence | |
| US 11,718,666 | Inhibitors of Neuroligin 4-Neurexin 1-BETA Protein-Protein Interaction for Treatment of Liver Disorders In force Fee due Feb 8, 2027 Lapses if unpaid Aug 9, 2027 · High confidence | Hadasit Medical Research Services and Development Ltd. | In force | Feb 8, 2027 | Aug 9, 2027 | High confidence | |
| US 10,392,617 | MIR-122* as an Active Micro-RNA, Compositions Comprising the Same and Uses Thereof In force Fee due Feb 27, 2027 Lapses if unpaid Aug 27, 2027 · High confidence | Hadasit Medical Research Services and Development Ltd. | In force | Feb 27, 2027 | Aug 27, 2027 | High confidence | |
| US 11,746,324 | Large Scale Production of Retinal Pigment Epithelial Cells In force Fee due Mar 5, 2027 Lapses if unpaid Sep 7, 2027 · Medium confidence | Hadasit Medical Research Services and Development Ltd. | In force | Mar 5, 2027 | Sep 7, 2027 | Medium confidence | |
| US 11,771,779 | Non-Metallic Magnetic Resonance Contrast Agent In force Fee due Apr 3, 2027 Lapses if unpaid Oct 4, 2027 · High confidence | Hadasit Medical Research Services & Development Limited | In force | Apr 3, 2027 | Oct 4, 2027 | High confidence | |
| US 10,441,568 | Nitroxide Radicals for the Treatment of Diseases of the Respiratory Tract In force Fee due Apr 15, 2027 Lapses if unpaid Oct 15, 2027 · High confidence | Hadasit Medical Research Services and Development Ltd. | In force | Apr 15, 2027 | Oct 15, 2027 | High confidence | |
| 13 more maintenance fees coming due in the 12 months from Nov 21, 2026 · Pro | |||||||
10 of 23 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.